The method presented described here allows the separation of trypanosomes, parasites responsible for animal and human African trypanosomiasis (HAT), from blood. This is the best method for diagnosis of first stage HAT and furthermore this parasite purification method permits robust serological and research investigation.
HAT is caused by Tsetse fly transmitted Trypanosoma brucei gambiense and T. b. rhodesiense1. These protozoan parasites multiply extracellularly in the bloodstream, lymph, and interstitial fluids during the first stage of the disease (hemolymphatic stage). The second stage (meningoencephalitic stage) begins when parasites cross the blood brain barrier; neurological signs, including a sleep disorder, which has given its name "sleeping sickness" to this disease, are typical of this second-stage2. Related trypanosomes (T. evansi, T. congolense, T. vivax, T. b. brucei) are the causative agents of animal African trypanosomosis (AAT)3.
The World Health Organization (WHO) aims to eliminate HAT as a public health problem by 2020 and to stop transmission by 20304. The recent introduction of rapid diagnosis tests has improved serological diagnosis1,4,5. Several molecular diagnostic tests have been developed but their role in field diagnostics has not yet been established5. They are used to identify the sub-species of the brucei group and atypical trypanosomiasis caused by parasites responsible for animal trypanosomosis6.
The detection of the parasite is essential for the diagnosis, treatment and follow-up, as serology can give false positive and unfortunately false negative results1. The direct microscopical observation of these hemoflagellate protists is difficult in HAT cases that are caused by T. b. gambiense, (more than 95% of cases) as low parasitemias are the rule, whereas for HAT caused by T. b. rhodesiense, a large number of parasites are frequently present in the blood. Various concentration techniques have been used, such as thick drop and capillary tube centrifugation (CTC), but the separation of parasites from blood by a column of anion-exchanger (DEAE cellulose) followed by centrifugation and microscopic observation of the pellet, is the most sensitive method (around 50 parasites/mL of blood can be detected)1,7. Consequently, the purification of trypanosomes by this anion-exchangers (DEAE cellulose) method is the best and, to date, the reference method for visualizing and isolating parasites from blood for HAT diagnosis. In field conditions, a mini-column of DEAE cellulose has been successfully used and several improvements have facilitated microscopical observation7,8.
The method of trypanosome separation from blood, described below, depends on parasite surface charge, which is less negative than mammalian blood cells9. Interestingly, this method was developed 50 years ago, in 1968 by Dr. Sheila Lanham, and remains the gold standard for detection and preparation of bloodstream trypanosomes. It is fast and reproducible for salivarian trypanosomes from a wide range of mammals, permitting the diagnosis of both animal and human trypanosomiasis10.
To obtain living, purified parasites, infected blood is added onto an anion-exchanger column. Chromatography conditions (mainly pH, ionic strength of buffers/media) have to be adapted to each trypanosome species, and more generally, to each mix of mammalian blood cells and trypanosomes10. Elution buffer is precisely adjusted to pH 8 for most African trypanosomes10. This method favors the concentration of parasites found in the blood of patients, because parasitemias can be too low to be detected by microscopic observation alone, and it also enables laboratory investigations. Working with freshly isolated trypanosomes and on blood from infected animals, using this technique, is more pertinent for various investigations than studies with parasites that have been cultured in axenic conditions in the laboratory for an indefinite period.
Host-parasite relationships are best studied with a parasite infecting its natural host, therefore, T. musculi, a natural murine parasite, which is representative of extracellular trypanosomes, has many advantages as murine infection involves in a small laboratory animal and does not require biohazard safety level (BSL) conditions. T. musculi does not kill immunocompetent mice, unlike many other Trypanosoma species, including human pathogens. T. musculi are not eliminated in T cell-deprived mice and parasitemias can be increased in infected mice by modifying food and nutrient intake11. This parasite modulates the immune response in co-infections with other pathogens12. T. musculi from infected mice exhibit differences from cultured T. musculi, for example, the expression of membrane Fc receptors is lost in T. musculi axenic cultures, compared to parasites purified from infected mice13,14. Excreted-secreted factors (ESF) are also qualitatively and quantitatively less expressed in axenic trypanosome cultures and differ between strains isolated in endemic areas15. ESF are the first antigens to be displayed to the host immune system and so play an important role in the initial host immune response16.
In experimentally infected animals for laboratory investigations, this protocol facilitates experimentation on a greater number of parasites, minimizing the number of mice required especially when using immunosuppressed animals. The variant surface glycoproteins (VSGs) that are used in the Card Agglutination Test for Trypanosomiasis (CATT) in mass screening are still purified from trypanosomes that are propagated in rats. The two rapid diagnostic tests (individually wrapped cassettes) that are now available for use in the field, are still using an infective model source of native VSGs and not in vitro cultured trypanosomes1,4,5. The advancement in the study of trypanosome immunology and biology has been facilitated since these DEAE cellulose purified parasites can be easily obtained in large quantities from naturally or experimentally infected hosts, and in particular, rodents.